In this episode, Rich Mazzola and Duane Mancini discuss Rich's background in the Medtech space, what we can expect from him as host of the Medtech Money podcast series and so much more.
In this episode, Giovanni Lauricella and Duane Mancini discuss Giovanni's time as the @medtech money podcast host, what he learned, the connections he made along the way and so much more.
In this episode, our host Giovanni Lauricella and our guest Hanson Gifford discuss his perspective on what makes Medtech companies successful, the entrepreneur side of raising capital, the investor side of investing capital, and so much more.
In this episode, our host Giovanni Lauricella and our guest Eric Goslau discuss his best and worst piece of advice he received while raising money, being resilient, what problem they are solving, lessons learned so far, and so much more.
In this episode, our host Giovanni Lauricella and our guest Steven Pacelli discuss how he helped find Dexcom Ventures, the mechanics of how, who, and why the invest, and so much more.
In this episode, our host Giovanni Lauricella and our guest Greg Walters discuss exiting his first company, what it takes to achieve an exit, the process of an acquisition, and so much more.
In this episode, our host Giovanni Lauricella and our guest Chris Bostick discuss investing with patients, providers, and payers mind, why fundraising is more challenging, this biggest challenge of being a venture capitalist, and so much more.
In this episode, our host Giovanni Lauricella and our guest Austin Sawyer discuss his background in founding a Medtech company, switching to venture capital, what books influenced his understanding venture capital, being a historian of venture capital, and so much more.
In this episode, our host Giovanni Lauricella and our guest Scott Nelson discuss his best and worst piece of advise he received about raising money, a no isn’t alway a no from an investor, raising money from a Chinese Strategic, and so much more.
In this episode, our host Giovanni Lauricella and our guest Josh Seidenfeld discuss being a corporate lawyer for startups, mitigating risks and mistakes, legal strategies for raising capital, building Medtech Startups, tax structure, and so much more.
In this episode, our host Giovanni Lauricella and our guest Laura Indolfi discuss angels vs. institutional money, Silicon Valley Bank, pitching to the wrong people, psychology that you must have while raising money, her Ted Talk, and so much more.
In this episode, our host Giovanni Lauricella and our guest Amar Sawhney discuss the biggest challenges at a Medtech Startup, challenges in raising capital for Medtech, minimizing risk for your investors, and so much more.
In this episode, our host Giovanni Lauricella and our guest Liridon Rrushaj discuss investing in Medtech, the importance of who you co-invest with, positives to being the venture arm of a hospital system, and so much more.
In this episode, our host Giovanni Lauricella and our guest William Dai discuss the most active fund in Medtech, what they look for when investing, why they are different, and so much more.
In this episode, our host Giovanni Lauricella and our guest Patrik Schmidle discuss his $2.3M seed round, the best piece of advice he received, the worst piece of advice, what he would change about the fundraising process, cap table management, and so much more.
In this episode, our host Giovanni Lauricella and our guest Mike Wallace at Devoro Medical discuss his role as a venture fund, selling to Boston Scientific, being a part of a team, 880 Medical, ShangBay Capital, build to buy, and so much more.
In this episode, our host Giovanni Lauricella and our guest Ted Bird discuss everything about crowdfunding, life lessons that he has carried with him to this day, how crowdfunding is perceived with investors, how they built their own platform using multiple crowdfunding channels, and so much more.
In this episode, our host Giovanni Lauricella and our guest Surbhi Sarna discuss why fundraising is so difficult, the best and worst advice she received when raising money, her exit to Boston Scientific, her book titled “Without A Doubt”, and so much more.
In this episode, our host Giovanni Lauricella and our guest Philippe Pouletty discuss why your business plan should be able to fit on the back of your business card, his background in the space, why he started a venture capital firm in France, what they look for before making an investment, how their fund works, where they invest, the story of the artificial heart, and so much more.
In this episode, our host Giovanni Lauricella and our guest Abigail Hunter-Syed discuss the hardest part of her job, corporate venture capital, best piece of advice for entrepreneurs raising money, OIV’s interest and where they invest, and so much more.
In this episode, our host Giovanni Lauricella and our guest Jenny Regan at Key Tech discuss succession planning and exiting for Medtech service providers, the best and worst piece of advice she received, ESOP plan, and so much more.
In this episode, our host Giovanni Lauricella and our guest Jay Goss at Wavemaker Three-Sixty Health discuss his background in the space, going from entrepreneur to early-stage VC, health tech vs. Medtech, what they look for in companies, stage of their companies they invest in and so much more.
In this episode, our host Giovanni Lauricella and our guest Julia Prakapovich at Interface Fund discuss her background in the space, why they chose the thesis they did at their fund, her entrepreneur journey, their link to Neuralink, what it means to be in deep tech and why they focus there, and so much more.
In this episode, our host Giovanni Lauricella and our guest Stephen Towe at Leo Cancerr Care discuss the worst piece of advice on how to raise capital, lessons learned from his various rounds, how he thought about raising capital and so much more.
In this episode, our host Giovanni Lauricella and our guest Bruce Lichorowic at Galen Robotics discuss the closing of their Series A capital raise, the importance of relationships when raising money, why they moved to Maryland, oversubscribing, and so much more.
In this episode, our host Giovanni Lauricella and our guest Ronit Harpaz at Endoron discuss her background in the medical device space, how she raised money, grants and non-dilutive capital in Israel, the importance of raising enough capital and oversubscribing if necessary, their investment from Sofinnova Partners, and so much more.
In this episode, our host Giovanni Lauricella and our guest Joe Rafferty at Vesteck discuss the bridge from angels to venture capitalists, how exit values drive early stage investing, great technologies and bad leaders, his strategy behind raising capital and how much, and so much more.
In this episode, our host Giovanni Lauricella and our guest Ramin Mousavi at CathWorks discuss what investors are truly investing in, the agreement and partnership with Medtronic, the importance of story telling, and so much more.
In this episode, our host Giovanni Lauricella and our guest Shamik Parekh from Octopus Ventures discuss how he discovered the true impact of capital, how he set-up an incubator for companies to help them scale, what kind of technology they invest in, what stage of the company they invest, how do they define HealthTech, what they look for in an investment, what their due diligence process looks like, his best advice for entrepreneurs on how they should reach out to investors, and so much more.
In this episode, our host Giovanni Lauricella and our guest Bryan Chambers discuss the impact of Capital Factory, innovation, the third coast, the Texas Fund, the Texas manifesto, Texas NeuroTech and so much more.
In this episode, our host Giovanni Lauricella and our guest Connor Glass discuss their seed-1 round, unconventional path to raising money, why he raised from VCs, human-machine interfaces and so much more.
In this episode, our host Giovanni Lauricella and our guest Alberto Rodriguez-Navarro discuss their technology, how they raised their Series C, surgical robotics, raising money in Latin America, Magnets, Physician-Entrepreneurs, Angels vs. VCs and so much more.
In this episode, our host Giovanni Lauricella and our guest Fady Saad discuss their $50M First Fund, starting a venture capital firm, mass robotics, and so much more.
In this episode, our host Giovanni Lauricella and our guest Farzad Soleimani discuss their second fund, software, SAFEs, angels, Texas innovation and so much more.
In this episode, our host Giovanni Lauricella and our guest Sidney Collin discuss their seed round, raising money before graduating college, the difference between angels and VCs, raising money around a class I medical device, and so much more.
In this episode, our host Giovanni Lauricella and our guest Darshana Zaveri discuss why their fund focuses on Medtech, current state of the economy and how that is affecting raising capital, where they invest, how they invest, stage and so much more.
In this episode, our host Giovanni Lauricella and our guest Michael Monovoukas discuss raising money for SaaS vs. hardware, what he has learned in his first time capital raising, pitching to VCs, the due diligence process, and so much more.
In this episode, our host Giovanni Lauricella and our guest David Kereiakes discuss taking a product to market in China, a global comparison of Medtech in different regions, how to raise money from strategics, and so much more.
In this episode, our host Giovanni Lauricella and our guest David Kereiakes discuss hospital venture groups, being resilient, differences between traditional VCs and hospital venture groups, voice of customer at a hospital venture group, type of fund, stage of companies they invest in and so much more.
In this episode, our host Giovanni Lauricella and our guest Frederik Groenewegen discuss why he likes being a venture capitalist, his relation to WL Gore, their first fund and how they started it, a medtech focused fund with a therapeutic focus, must haves in a pitch deck and so much more.
In this episode, our host Giovanni Lauricella and our guest Dave Marver discuss taking a company public, the importance of building a brand, the importance of intellectual property, what are some of the differences and similarities between private and public companies, and so much more.
In this episode, our host Giovanni Lauricella and our guest Jonathan Ng discuss the largest series of financing we have had on the podcast so far of $150M in a series B, the most investable skill set, how they named their companies, their focus on GI, not knowing what a VC was 4.5 years ago and how he got here, don’t take “No” personally, balancing your board, and so much more.
In this episode, our host Giovanni Lauricella and our guest Amy Kruse discuss the most investable skill set of an entrepreneur, her background in neuroscience, what areas they want to invest in, why they like to lead or co-lead a round, what round they invest in, determining if she really wants to work with someone and how that factors into writing a check, the importance of seeking advice from seasoned entrepreneurs and so much more.
In this episode, our host Giovanni Lauricella and our guest Louis Cannon discuss the importance of CEO motivation in startups, why he became a venture capitalist, the importance of his experience as a practicing physician, why they are geographically agnostic, who typically are their limited partners, what round they typically invest in, what boxes need to be checked before investing, what he looks for in a pitch deck, and so much more.
In this episode, our host Giovanni Lauricella and our guest Bart Sanders discuss the importance of being humble, his decision to make the leap into founding Stentit, the Medtech hub being built in Eindhoven, his first steps if you are a first time entrepreneur raising capital, the importance of grants to help get the company going, the importance of a good ecosystem for a startup, building relationships with investors, how long it took to raise the seed round, the importance of warm introductions and so much more.
In this episode, our host Giovanni Lauricella and our guest Brian Fahey discuss the importance of finding people who will debate with you, what it is like to raise money for a class III medical device, what is the status in the market of investors that will invest in class III, why it is important to be targeted in who you pitch to and who you approach for money, what is Shifamed, what kind of products they focus on, the importance of getting previous investors with dry powder available to invest in your current round, and so much more.
In this episode, our host Giovanni Lauricella and our guest Dan Lemaitre discuss the importance of setting milestones so your investors can keep score, BlueWind’s connection to Rainbow Medical, when hiring team members what does he look for, what they are working on a BlueWind Medical, the importance of spending time with patients, how he raised the series A and series B, how they chose the strategic they wanted to work with, why he wants to take the company public, and so much more.
In this episode, our host Giovanni Lauricella and our guest Daniel Powell discuss the most investable skill set an entrepreneur can have, his background in the medical device space, what they are working on a Spark Biomedical, where they currently are and where they are going, not being selfish on the terms, why he gave voting rights to the early investors, the ups and downs of his first round, where he raised money from, the different groups he raised from, and so much more.
In this episode, our host Giovanni Lauricella and our guest Dan Gelvan discuss the importance of hard-work, talent and luck, what he is doing with t-style, why he prefers venture studio over incubator, how to work with family offices, the pigeon model of running a board, why as a VC you always have to look at the next round and not the one you are currently investing in, the value of a family office, the importance of a board, what makes Israel’s ecosystem so great, and so much more.
In this episode, our host Giovanni Lauricella and our guest Sebastian Anastassiou discuss the importance of building relationships with investors, his background, Nina Capital’s link to the Stanford Biodesign program, their focus on pre-seed and seed stage companies, mechanics of how they invest, when, where, and how much, the success of the first fund and how that led to the second fund, the effect of EU MDR, the Medtech ecosystem in Spain, how to start a young venture capital firm and so much more.
In this episode, our host Giovanni Lauricella and our guest David Sylvan discuss the importance of coach-ability, why he feels he has one of the best jobs at University Hospitals, his background of how he got into investing and his role at UH, the importance of soft skills when working with teams, the various ways that University Hospitals Ventures can engage companies, the strategic focus of UH Ventures, the history of hospital venture groups, and so much more.
In this episode, our host Giovanni Lauricella and our guest Sam Ifergan discuss what does it mean to be a venture capitalist in Canada, how venture capitalist come up with investment thesis’s, the most investable skill set of an entrepreneur, his own entrepreneurial story, the basics about how they invest, where they invest and average check size, the different funds at iGan Partners, why Canadian Medtech companies are having smaller exits, the underserved innovation hubs, iGan Arabia, and so much more.
In this episode, our host Giovanni Lauricella and our guest Ruben Osnabrugge discuss the one thing he looks for in every entrepreneur he invests in, his switch from physician to investor, where does EQT Life Sciences invest, the largest fund in Europe, what stage of company will they invest in, the value add when a physician is added to a venture capital firm, the EU MDR’s effect on innovation in Europe, the due diligence process, and so much more.
In this episode, our host Giovanni Lauricella and our guest JD Friedland discuss the one thing JD looks for in an entrepreneur he invests in, the history of investing in Medtech and the constant changing paradigm, an overview of Cleveland Clinic Innovations, what they look for in an investment, the convergence of Medtech and digital health, how they engage with clients and how far they will support them, how big of checks will they write, updates in corporate venture capital and so much more.
In this episode, our host Giovanni Lauricella and our guest Mina Fahim discuss their $10 million seed round, the importance of trust within your company and team, the difference between timing vs. luck and the confusion between both, culture within and outside the company, how he met the company, how they raised almost $10 million in a SAFE, why investors invest in the team and storyline, get comfortable hearing no, and so much more.
In this episode, our host Giovanni Lauricella and our guest Tom Gerhardt discuss who he is and what his company is doing, what it is like being a Medtech entrepreneur in South Africa, his journey of being thrown into raising capital for the first time, the importance of getting outside your comfort zone in order to grow, how his days change so often and are never the same, who he looked for in his partners and investors, and so much more.
In this episode, our host Giovanni Lauricella and our guest Keith Matheny discuss being a physician entrepreneur, the importance of common sense, his various companies, the downfall of physicians not getting any business training during medical school, the importance of connecting and networking, what it is like being an entrepreneur, what it was like figuring out he had to take external funding and where did he start, weekly accountability meetings and why he does this in all his companies, and so much more.
In this episode, our host Giovanni Lauricella and our guest Daniel Adler from BioT discuss what they are working on at BioT, what makes Israel’s ecosystem so great for innovation, raising a $6.5 million seed round, differences between software vs. hardware in Medtech, what can a bad board do to a company, what he has learned as an entrepreneur on how to raise capital, and so much more.
In this episode, our host Giovanni Lauricella and our guest Tamir Meiri from Johnson and Johnson discuss corporate venture capital, the differences between corporate venture capital and traditional venture capital, the importance of timing and luck, what an average work week looks like for him, the support one would get from JJDC beyond just money, the different geographies they invest in, how much they typically invest, timing for a startup to actually have the money hit their bank account, and so much more.
In this episode, our host Giovanni Lauricella and our guest Hamman de Vaal from AdjuCor GmbH discuss what it’s like to work with an investment banker, the uniqueness of raising capital out of china, what it is like being a European Startup, bypassing a traditional series A round, negotiations with China investments, and so much more.
In this episode, our host Giovanni Lauricella and our guest Catello Somma from TVM Life Sciences discuss what goes on behind the scenes once a startup reaches out to an investor, why they do early-stage biotech but late-stage Medtech, slide deck vs. executive summary, the importance of scientific advisory boards, what should entrepreneurs be putting in their slide deck, the due diligence process, who do they call on during their diligence process, and so much more.
In this episode, our host Giovanni Lauricella and our guest Catherine Boule from Karista discuss why 100% of their business plans are wrong and why this is normal for the stage of company they are investing in, where and who they invest in, what they would like to do in their next fund, their focus on digital health, challenges startups face, why they only focus on France and Western Europe, the converging and merging of Medtech and Digital health and so much more.
In this episode, our host Giovanni Lauricella and our guest Graeme Smith from Lightpoint Medical discuss leading a commercial stage Medtech company, taking over a startup with a goal of exiting to a strategic or going public, his experience with Cancer and the problem that they are trying to solve, the relationship with Medtech distributors, the reason for calling it a Series C1 and Series C2, the dynamic between Graeme and the previous CEO, the valuation of a pre-revenue Medtech company, working towards his 6th exit, and so much more.
In this episode, our host Giovanni Lauricella and our guest Andreas Forsland from Cognixion discuss how innovating at a startup vs. a large Medtech player differ, the intersection of Medtech, Deeptech, and Consumer Tech, his motivation for why he founded Cognixion, their goal of 100 million voices unlocked, the metaverse and Web 3.0, product adoption in high-tech spaces, raising capital for the first time and his very first steps, getting venture dollars first and then non-dilutive capital, why they opened up in Canada, why the seed round was so large, and so much more.
In this episode, our host Giovanni Lauricella and our guest Renee Ryan from Cala Health discuss her background in investment banking, her transition to an investor, what they are working on at Cala Health, working with a board, closing their financing rounds, best advice for startup companies, and so much more.
In this episode, our host Giovanni Lauricella and our guest David Suendermann-Oeft from Modality.AI discuss what the transition was like going from academia to startup CEO, what problem his company is solving, raising capital as software as a medical device, the time it took to close the $2.1 million round, their experience with raising early-stage money, what type of investors were in their early rounds, and so much more.
In this episode, our host Giovanni Lauricella and our guest Soumya Mahapatra from Essenvia discuss what it is like to be a Co-Founder & CEO, the problem they are solving at Essenvia, SAFEs vs. Convertible note vs. Priced equity rounds, family and friends round for SaaS, how he closed a round in two weeks from his first check, why he did due diligence on his investors, and so much more.
In this episode, our host Giovanni Lauricella and our guest Manuel Opitz from Deepeye discuss the importance of people when forming a Medtech startup, what they are working on at Deepeye, the advantages and disadvantages of MDR, his lessons learned while raising capital, the differences in traditional Medtech and software when raising money, the importance of doing due diligence on your investors, and so much more.
In this episode, our host Giovanni Lauricella and our guest Antoine Papiernik at Sofinnova Partners discuss the grit and time it takes to be a successful venture capital investor, his background with Sofinnova, what Sofinnova does and where they invest, why he invests in Medtech, Why Shockwave is his #1 Medtech story, the major differences between US and European investors, his thoughts on the MDR, the shift we are going to see in investors from around the globe looking at Medtech companies, why Sofinnova stands out, their most recent $548 million early-stage healthcare fund, and so much more.
In this episode, our host Giovanni Lauricella and our guest Luca Ravagnan from Wise SRL discuss what his team is working on at Wise, the story of a researcher taking a company from inception to Series C, the effort that went into each round, the importance of local awards, why a mentor when you are starting out is helpful, the major learning moments going from R&D founder to CEO of commercialization and so much more.
In this episode, our host Giovanni Lauricella and our guest Fionn Lahart from OneProjects discuss becoming an entrepreneur, the Bioinnovate program in Ireland, the product they are working on at OneProjects, how he met Christoph Hennersperger (Co-Founder)and how they deal with running a company while being located in two different countries, the naming of their rounds and why they did it the way they did, how he raised capital as a first time entrepreneur, the importance of a slide deck and not over complicating it, and so much more.
In this episode, our host Giovanni Lauricella and our guest Robert Hamilton from NovaSignal discuss the “glamour” of being a Medtech startup executive, why access to blood flow was such a problem and how he discovered the problem, the “mistake” he made in code that lead to NovaSignal, understanding how to fill your talent gaps as a founder, how he got the first money in the door, the skill set required to manage a board, understanding how to raise capital to hit that next milestone, not being greedy and raising too much money, and so much more.
In this episode, our host Giovanni Lauricella and our guest Todd Usen from Activ Surgical discuss his focus on people and teamwork at Activ Surgical, his background in the Medtech space at Boston Scientific, Smith & Nephew, and Olympus Medical, what Activ Surgical is solving, how they have raised $77 million to date, what were the most important parts in raising the capital, what makes a venture capital group the right partner, putting an investor deck together at a startup and so much more.
In this episode, Giovanni Lauricella and James Eadie discuss why he loves Medtech investing, his background in becoming an investor, what is Sante, who they invest in, how they invest, what they look for, their new $260 million dollar fund, the mechanics of investing, the importance of strategy when raising capital early, evaluations in early rounds, his advice and pitfalls and so much more.
In this episode, Giovanni Lauricella and Peter Vranes discuss his background as an entrepreneur, how they founded Nutromics, what the company is doing, where does Australia fit in the global MedTech industry, the advantageous clinical trial environment in Australia, their experience raising capital and closing their most recent round, the lack of investors and how that affects startups in Australia, their experience with Medtech Innovator, why Peter always takes investor meetings, and so much more.
In this episode, Giovanni Lauricella and Cristiano Fontana discuss how they came up with the name Three Bridges M&C, his background in the medical device and how he works with early stage startups to fill their gaps, differences in raising money from different kinds of investors, pre-market evaluations, why evaluations are so high, discussing why company evaluations change country to country, and so much more.
In this episode, Giovanni Lauricella and Janelle Goulard discuss her background in the healthtech space, their focus around advanced materials, why they invest in hardtech, their average check size, what geographies they invest in, the evolution of their five funds, the exit times in Medtech and why that influenced them to move to later stage, their preference of how deal flow comes to them, and so much more.
In this episode, our host Giovanni Lauricella and our guest Daniel Hawkins from Avail Medsystems discuss his $100 million raise, his experience at Intuitive Surgical and what it was like to be employee number 6, his exit to Johnson and Johnson, his experience in raising money at Sofinova, his promise he made to investors, he discusses his strategy around IP with his companies, how he raised $100 million over zoom, his relationship with Fred Moll, advice for startups and so much more.
In this episode, Giovanni and Ahmed discuss how far $14,000 can go if you are capital efficient, the bioenter program at University of California - Irvine, how he founded his company, how he raised their initial sum of money, the importance of constant communication with investors, and so much more.
In this episode, Giovanni and Eyal discuss the fascinating reason why they chose the name Peregrine Ventures, his history in the Medtech space, where their various funds invest in the lifecycle of a Medtech company, comparing Israel to the other health science startup hubs, the future of Israel and how it will center around manufacturing technology, and so much more.
In this episode, Giovanni and Juan discuss how they came up with the name, Keiretsu Forum, how the group was founded, the size of their group, the number of deals they do a year, the various skills that you should develop as a Medtech Startup CEO, how much they typically invest and when they can expect the money to hit the bank account, why selling is so important as an entrepreneur and so much more.
In this episode, Giovanni, Emily and David discuss grand funding from the NIH, the small business funding group she oversees, her background in the health tech space, why entrepreneurs might want to get non-dilutive NIH funding, the mechanics of how this non-dilutive funding works, the blueprint Medtech program, how they provide access to resources, and so much more.
In this episode, Giovanni and Gautam discuss “doing the right the thing” and the good karma it will bring, his role at The Capital Partnership, the typical check size of each of their funds, where he sees the Medtech space going in the future, their strategy when investing in companies, their connection to Schfimed companies, where there current investments have been, why they invest so heavily in the US and more.
In this episode, Giovanni and Anne discuss Sofinnova and where they focus their investments, MD Start and the relationship between MD Start and Sofinnova, her new start-up company called Moon Surgical, being with something from inception through exit and how that math works from an investment side, and more.
In this episode, Giovanni and Sascha discuss how he became the Managing Partner at SHS, where they focus from a stage of company and geographical area, the hardline of having revenue before they invest, the major differences of going public in the US and Europe for later stage companies, the affect of EU MDR on the region and innovation, their due diligence process, and more.
In this episode, Giovanni and Juan discuss how the name of Action Potential Venture Capital came about, what kind of technology they focus in and how they choose their investments, what round they prefer to invest, how does being a corporate venture capital firm acting as traditional venture capital group affect their investment, and more.
In this episode, Giovanni and James discuss creating a culture at a start-up that people want to be a part of, how he founded Access Vascular, why doing sales was important for his success as a Medtech CEO, the ability to find and fill the gaps as a Medtech startup, how he raised money for Access Vascular, his tips for Medtech companies for overall success and success in raising capital, and more.
In this episode, Giovanni and Yoav discuss what Health IL is, how are they funded and what their focus is, how they work with Israel startup companies, what makes Israel so special, what is Israel’s limitations, and more.
In this episode, Giovanni and Oliver discuss corporate venture, how Intuitive works with startups in the Medtech space, how they invest, the due diligence process from a strategic vs. venture capital group, how they evaluate potential investments, future funds, and more.
In this episode, Giovanni and Lucien discuss raising capital from China, China’s massive interventional cardiology market, how they used Mavie to help raise capital in China, the timeline of raising capital, their relationship with Microport, what value does an investment banker bring, and more.
In this episode, Giovanni and Thom discuss what it is like to be a venture capital group in Europe, how the MDR is affecting Medtech deal flow, where they focus their investments, the importance of the experience of selling something, the similarities between marketing and venture capital, and more.
In this episode, Giovanni and John discuss his role and what they do at Accelmed, what is private equity, the difference between private equity vs. venture capital, what they look for in an investment, and more.
In this episode, Giovanni and Zied discuss raising capital as an early stage start-up in Europe, the various challenges of being a Medtech CEO, his personal connection to the technology, and more.
In this episode, Giovanni and Howard discuss how he got into the medical technology space, the technology his team is working on at Lumiheal, how his background as a lawyer has helped him run his company thus far, negotiating terms with initial investors, difference between late stage and early stage investing, success being more important than dilution, the importance of networking as a CEO, and more.
In this episode, Giovanni and Kelly discuss what he is currently working on at Fisher Wallace Laboratories, why he chose crowd funding as a source of capital for his Medtech start-up, how to crowd fund, what you need to do with the SEC, which platform they used and why they chose it, and more.
In this episode, Giovanni and Howard discuss being a part of Life Science Angels, what his team is working on at Tesa Medical, the mechanics of how angels invest, the different strategies they employ, safes vs. notes, price rounds, and more.
In this episode, Giovanni and Olivier discuss how Andera Partners was founded, when they invest in companies, how they build their portfolio of companies, how they have continued to invest in small companies with being such a large fund, what kind of companies they invest in, and more.
In this episode, Giovanni and Charlie discuss what they are doing at Modulim, the first money that came in the door, their different rounds of funding, how they made non-dilutive funding last so long, when it makes sense to pursue non-dilutive funding, why the name of your round matters, and more.
In this episode, Giovanni and Jen discuss how she got involved in the space, what her fund invests in, contrasting time to exit for Biotech vs. Medtech, failure rates of an investment in Medtech, the MDR and how it is affecting deal flow in Europe, the Medtech ecosystem in Ireland, women in Medtech and more.
In this episode, Giovanni and Gaston discuss early stage investments in Medtech, how they invest on a deal by deal basis through network of investors, the Medtech scene in France and Europe as a whole, filling the gap in France between early stage investors and late stage investors, how the French government is supporting innovation, how the MDR is affecting Medtech deal flow, and more.
In this episode, Giovanni and Tracy discuss the Stanford design program, how Materna Medical was founded, discusses their two seed rounds and series A round, why she called it a series 2A, the ignite fire pitch event, the importance of naming your round properly, and more.
In this episode, Giovanni and Thomas discuss what an investment banker can do for a Medtech start-up, how they can help work strategics, the life of an investment banker, the minimum raise an investment banker will get involved in, and more.
In this episode, Giovanni and Paul discuss Medtech Innovator, how they add value to a start-up company, common errors he used to see in start-up companies, the mechanics of how Medtech Innovator works, how they prepare their companies for external capital and more.
In this episode, Giovanni and Florian discuss how venture capital works in BENELUX, going from Medtech entrepreneur to a VC, new hubs that are forming in Medtech in Europe, and more.
In this episode, Giovanni and Tom discuss founding and managing a midwestern fund, the relationships they must build to be successful, why they are so focused on investing in Medtech, raising money as a venture capital fund, and more.
In this episode, Giovanni and Michael discuss quitting medical school to launch a medical device start-up company, raising capital for the first time, East Coast vs. Midwest vs. West Coast investors, the importance of telling your story as an entrepreneur, lessons learned along the way, and more.
In this episode, Giovanni and Simon discuss raising capital as a European company in software as a medical device (SaaS), being on the phone with an investor during a heist, and more.
In this episode, Giovanni and Reinhard discuss raising capital as a first time CEO in Europe, lessons learned along the way, raising capital from Nestle, various strategies he deployed, and more.
In this episode, Giovanni and Jeroen discuss what does BOM stand for, their investment strategy, their geographic focus, Medtech in the Netherlands, and more.
In this episode, Giovanni and Casey discuss the importance of having a good attorney when raising capital in the medtech space, case studies from his past, and more.
In this episode, Giovanni and Anish discuss his path to becoming a venture capitalist, the Medtech ecosystem in Canada, how Amplitude Ventures invests, what they are looking for in a Medtech company and more.
In this episode, Giovanni and Alessio discuss the start-up scene in Italy, investing in Europe, how he raised a 150 million euro second fund, how they invest in Medtech and more.
In this episode, Giovanni and Gur discuss his background in becoming an investor, aMoon investment fund, how they invest, why they love Medtech, investing in both early and late-stage, the Israel Medtech scene and more.
In this episode, Giovanni and Chris discuss raising Series A as a software as a service or Saas, convertible notes vs. SAFEs, raising seed rounds, bridge rounds in between, how to pitch and lessons learned along the way and more.
In this episode, Giovanni and Marc discuss the digital health capital raising landscape, raising money for two different companies at the same time and deploying two different strategies and more.
In this episode, Giovanni and Ash discuss his journey in the medical device space, being an entrepreneur in Australia, the Medtech scene in Australia and more.
In this episode, Giovanni and Orrin discuss his journey from being a doctor to an investor, what is a micro VC, the value of physician investors as an early stage start-up, and more
In this episode, Giovanni and Yaniv discuss what angel investors look for, the mechanics of the invest group, how and where they invest, managing a cap table, the diagnostic sector and why they aren't investing as much there, and more
In this episode, Giovanni and Alexandra discuss Alix’s story of becoming a venture capital parter, what her group looks for in investments, how much they invest and when, and more.
In this episode, Giovanni and Eric discuss how strategics evaluate Medtech start-ups, positives to engaging strategics early in raising money, understanding timelines and the decision process internally at corporates and more.
In this episode, Giovanni and Geoff discuss late-stage venture capital investing, the difference and similarities between EU vs. US, insights and advice for companies raising money, and more.
In this episode, Giovanni and Jeff discuss his background going from the army to medical sales to a first time CEO, lessons learned while raising money for the first time and more.
In this episode, Giovanni and Olivier discuss raising capital in China, when someone might want to look at raising capital from China, how they do this, positives and negatives, downstream effects and more.
In this episode, Giovanni and Bryce discuss raising capital from angel groups, the differences between angels and VCs, east vs. west coast investors and more.
In this episode, Giovanni and Carl discuss everything angel investing from how to engage, when to engage, what they look for, typical check sizes, managing a cap table and more.
In this episode, Giovanni and Brian discuss raising seed funding from a first time entrepreneur point of view, the decision to leave corporate, taking on an entrepreneur mindset, and more.